COMMUNIQUÉS West-GlobeNewswire

[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum in the third quarter with sales growth of +7% at constant exchange rates (CER) and +8% in CHF; Group sales increase +6% (CER), +1% in CHF, in the first nine […]
22/10/2026
Ad hoc announcement pursuant to Art. 53 LR Basel, 22 October 2026 Roche continues strong momentum in the third quarter with sales growth of +7% at constant exchange rates (CER) and +8% in CHF; Group sales increase +6% ( [...]
Pharming Group announces third quarter 2026 revenues above market expectations
22/10/2026
Third quarter 2026 total revenues increase by 21% to approximately US$117.6 million, compared to third quarter 2025 Third quarter 2026 total operating expenses of approximately US$74.6 million, in line with third [...]
argenx Reports Third Quarter 2026 Financial Results and Provides Business Update
22/10/2026
Continued strong VYVGART performance drives $1.7 billion in global product net sales, representing 54% year-over-year growth and 13% quarter-over-quarter growth sBLA for VYVGART Hytrulo in IMNM on track for submission [...]
Une nouvelle étude sur EggNest® publiée dans JAHA et une dérogation réglementaire au Texas confirment l’évolution vers des procédures sans tablier plombé en salle de cardiologie interventionnelle
22/10/2026
MINNEAPOLIS, 22 oct. 2026 (GLOBE NEWSWIRE) -- Egg Medical a annoncé aujourd’hui la publication d’une étude prospective dans le Journal of the American Heart Association (JAHA), évaluant ses dispositifs renforcés de [...]
Supernus Announces Orphan Drug Exclusivity for ONAPGO™ (apomorphine HCl)
22/10/2026
Orphan-drug exclusivity provides seven years of market exclusivity for ONAPGO Additionally, the Company submitted an sNDA to the FDA for a second supplier for ONAPGO, with potential approval by mid-year 2027 ROCKVILLE, [...]
Asimov Announces Adoption of Its AI-Driven Cell Line Development Platform by LG Chem
22/10/2026
Asimov’s CHO Edge System, including the recently announced Chrysalis transposase and Kernel, Asimov’s AI-driven genetic design software, will support LG Chem’s biologics cell line development activities BOSTON, Oct. 21 [...]
Teknova to Report Third Quarter 2026 Financial Results on November 4, 2026
22/10/2026
HOLLISTER, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]
Kane Engages Independent Trading Group as Market Maker
21/10/2026
Agreement intended to support an orderly market and improve liquidity in Kane Biotech’s common shares WINNIPEG, Manitoba, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane [...]
Helus Pharma Highlights Clinical Program Advancements at Investor Presentation Held on October 21, 2026
21/10/2026
Topline data readout from APPROACH Phase 3 study of HLP003 in development for the potential adjunctive treatment of major depressive disorder (“MDD”) on track for Q4 2026 1,2 HLP004 Program progressing with Phase 2 [...]
EmblemHealth Celebrates New York’s Labor Leaders at 14th Annual Heroes of Labor Awards
21/10/2026
Annual celebration recognized advocates for worker’s rights, safety, and well-being across New York City Left to right: Christine O’Connor, AVP, NYC Strategic Relationships, EmblemHealth, Karen Ignagni, Chief Executive [...]
Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
21/10/2026
MENLO PARK, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, [...]
Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026
21/10/2026
FREMONT, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced that it will report financial results for the third quarter of 2026 after [...]
Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
21/10/2026
SAN JOSE, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]
SCYNEXIS to Feature SCY-247 in a Pipeline Presentation at IDWeek
21/10/2026
JERSEY CITY, N.J., Oct. 21, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX) (“SCYNEXIS” or the “Company”), a clinical-stage biotechnology company dedicated to advancing innovative solutions for severe rare [...]
Seer to Report Third Quarter 2026 Financial Results on November 10, 2026
21/10/2026
REDWOOD CITY, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the [...]
Revolution Medicines to Report Financial Results for Third Quarter 2026 After Market Close on November 4, 2026
21/10/2026
REDWOOD CITY, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for [...]
Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib in Chronic Myelomonocytic Leukemia
21/10/2026
SAN DIEGO, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel cancer therapies, today announced that the U.S. Food [...]
BioCryst to Report Third Quarter 2026 Financial Results on November 4
21/10/2026
RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its third quarter 2026 financial results on Wednesday, November [...]
Arcutis to Report Third Quarter 2026 Financial Results and Host Conference Call on November 4, 2026
21/10/2026
WESTLAKE VILLAGE, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum